Rituximab in Idiopathic Membranous Nephropathy

Selective depletion of B cells with the mAb rituximab may benefit the autoimmune glomerular disease idiopathic membranous nephropathy (IMN). Here, we describe our experience treating 100 consecutive IMN patients with persistent nephrotic syndrome with rituximab. We defined complete remission as pers...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ruggenenti, Piero, Cravedi, Paolo, Chianca, Antonietta, Perna, Annalisa, Ruggiero, Barbara, Gaspari, Flavio, Rambaldi, Alessandro, Marasà, Maddalena, Remuzzi, Giuseppe
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2012
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3402291/
https://ncbi.nlm.nih.gov/pubmed/22822077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2012020181
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller